Request Deal Involvement

Amryt Pharma to acquire Chiasma for $330m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Goodwin Procter

legal advisors

Goodwin Procter

Duff & Phelps

financial advisors

Duff & Phelps

Torreya Capital

financial advisors

Torreya Capital

Moelis & Co

financial advisors

Moelis & Co

Shore Capital & Corporate

financial advisors

Shore Capital & Corporate

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

Consilium Strategic Communications

pr advisors

Consilium Strategic Communications

LifeSci Partners

pr advisors

LifeSci Partners

or

Principals

HIGHBRIDGE CAPITAL MANAGEMENT

bidder

HIGHBRIDGE CAPITAL MANAGEMENT

CHIASMA

target

CHIASMA

AMRYT PHARMA PLC

bidder

AMRYT PHARMA PLC

ATHYRIUM CAPITAL MANAGEMENT

bidder

ATHYRIUM CAPITAL MANAGEMENT

MPM CAPITAL

bidder

MPM CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite